Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

Stephanie A. Amiel; Pablo Aschner; Belinda Childs R N; Philip E. Cryer; Bastiaan E. de Galan; Simon R. Heller; Brian M. Frier; Linda Gonder-Frederick; Timothy Jones; Kamlesh Khunti; Lawrence A. Leiter; Rory J. McCrimmon; Yingying Luo; Elizabeth R. Seaquist; Robert Vigersky; Robert Vigersky; Sophia Zoungas

doi:10.1007/s00125-016-4146-6

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

Stephanie A. Amiel, Pablo Aschner, Belinda Childs R N, Philip E. Cryer, Bastiaan E. de Galan, Simon R. Heller, Brian M. Frier, Linda Gonder-Frederick, Timothy Jones, Kamlesh Khunti, Lawrence A. Leiter, Rory J. McCrimmon, Yingying Luo, Elizabeth R. Seaquist, Robert Vigersky, Robert Vigersky, Sophia Zoungas

UWA Centre for Child Health Research (affiliated with the The Kids Research Institute Australia)

Research output: Contribution to journal › Article › peer-review

276 Citations (Web of Science)

Original language	English
Pages (from-to)	3-6
Number of pages	4
Journal	Diabetologia
Volume	60
Issue number	1
DOIs	https://doi.org/10.1007/s00125-016-4146-6
Publication status	Published - 1 Jan 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00125-016-4146-6Licence: Unspecified

Cite this

Amiel, S. A., Aschner, P., Childs R N, B., Cryer, P. E., de Galan, B. E., Heller, S. R., Frier, B. M., Gonder-Frederick, L., Jones, T., Khunti, K., Leiter, L. A., McCrimmon, R. J., Luo, Y., Seaquist, E. R., Vigersky, R., Vigersky, R., & Zoungas, S. (2017). Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes. Diabetologia, 60(1), 3-6. https://doi.org/10.1007/s00125-016-4146-6

@article{7623a858cc6d45daae46247e3fcffb76,

title = "Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes",

author = "Amiel, {Stephanie A.} and Pablo Aschner and {Childs R N}, Belinda and Cryer, {Philip E.} and {de Galan}, {Bastiaan E.} and Heller, {Simon R.} and Frier, {Brian M.} and Linda Gonder-Frederick and Timothy Jones and Kamlesh Khunti and Leiter, {Lawrence A.} and McCrimmon, {Rory J.} and Yingying Luo and Seaquist, {Elizabeth R.} and Robert Vigersky and Robert Vigersky and Sophia Zoungas",

year = "2017",

month = jan,

day = "1",

doi = "10.1007/s00125-016-4146-6",

language = "English",

volume = "60",

pages = "3--6",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "1",

}

Amiel, SA, Aschner, P, Childs R N, B, Cryer, PE, de Galan, BE, Heller, SR, Frier, BM, Gonder-Frederick, L, Jones, T, Khunti, K, Leiter, LA, McCrimmon, RJ, Luo, Y, Seaquist, ER, Vigersky, R, Vigersky, R & Zoungas, S 2017, 'Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes', Diabetologia, vol. 60, no. 1, pp. 3-6. https://doi.org/10.1007/s00125-016-4146-6

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes. / Amiel, Stephanie A.; Aschner, Pablo; Childs R N, Belinda et al.
In: Diabetologia, Vol. 60, No. 1, 01.01.2017, p. 3-6.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials

T2 - a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

AU - Amiel, Stephanie A.

AU - Aschner, Pablo

AU - Childs R N, Belinda

AU - Cryer, Philip E.

AU - de Galan, Bastiaan E.

AU - Heller, Simon R.

AU - Frier, Brian M.

AU - Gonder-Frederick, Linda

AU - Jones, Timothy

AU - Khunti, Kamlesh

AU - Leiter, Lawrence A.

AU - McCrimmon, Rory J.

AU - Luo, Yingying

AU - Seaquist, Elizabeth R.

AU - Vigersky, Robert

AU - Zoungas, Sophia

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=84996598780&partnerID=8YFLogxK

U2 - 10.1007/s00125-016-4146-6

DO - 10.1007/s00125-016-4146-6

M3 - Article

C2 - 27872948

AN - SCOPUS:84996598780

SN - 0012-186X

VL - 60

SP - 3

EP - 6

JO - Diabetologia

JF - Diabetologia

IS - 1

ER -

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

UN SDGs

Access to Document

Other files and links

Cite this